CCR2 and neoplasm: In the tumor microenvironment, knockout of CCR2 or intervention with CCR2 antagonists can inhibit HCC tumor growth and metastasis by regulating the recruitment and polarization of tumor-associated macrophages (TAMs) and can improve survival in mouse HCC models (13).